Likewise, mouse Lewis lung cancer model revealed a noncanonical CARD9/NF-κB/IDO pathway, which can limit tumor progression through inhibiting the immunosuppressive capacity of MDSCs (212). Here, NFKB1 is linked to neoplasm.